German health care and science group Merck has sealed a deal to bolster its cancer treatment portfolio with a US$3.9 billion ...

Harvard frantically tried to avoid a showdown with the Trump administration. Now many of its big donors are pushing the ...

A bitter management shake-up. Angry public outbursts. A “narcissistic” pastor whose word is gospel. What in God’s name is happening to the once-mighty pop icon? “Whatever he’s going through, I pray ...

Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 ...

German health care and science group Merck has sealed a deal to bolster its cancer treatment portfolio with a $3.9-billion ...

Halozyme (HALO) filed a patent infringement lawsuit against Merck (MRK) in U.S. District Court in New Jersey. Halozyme believes the ...

Merck KGaA’s $3.9 billion deal to buy SpringWorks Therapeutics Inc. will expand the German conglomerate’s presence in the US ...

Germany's Merck is on the verge of a billion-euro takeover of US biopharmaceutical company Springworks Therapeutics, with the ...

(Reuters) -Germany's Merck KGaA is nearing a roughly $3.5 billion deal for SpringWorks Therapeutics, the Wall Street Journal ...

Halozyme Therapeutics (NASDAQ:HALO) on Thursday announced a lawsuit against Merck (NYSE:MRK) over allegations that an injectable version of the New Jersey-based pharma giant’s blockbuster cancer ...

RAHWAY, N.J. (AP) — RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported first-quarter earnings of $5.08 billion. On a per-share basis, the Rahway, New Jersey-based company said it had ...